One of the mechanisms is by binding of PD-L1, which is found on tumor and antigen presenting cells, to programmed cell death protein 1 (PD1) which is found on activated T-cells, therefore blocking T-cell activation and inhibiting T-cell killing of tumor cells [68]. The gene discussed is PDCD1; the disease is neoplasm.